Novel protocol for the solid-phase synthesis of peptidyl and peptidomimetic P1-argininal derivatives

Tetrahedron Letters

Volumn 40, Issue 28, 1999, Pages 5123-5127

  Siev, Daniel V ^a   Gaudette, John A ^a   Semple, J Edward ^a  

^a Dendreon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; CYSTEINE PROTEINASE INHIBITOR; PEPTIDYL ARGININAL DERIVATIVE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS; SOLID;

EID: 0033538601     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00870-9     Document Type: Article

References (44)

1. Leading recent reviews: (a) Ellingboe, J. W. Med. Chem. Res. 1998, 8, 181.
2. (b) Sucholeiki, I. In Comb. Chem.; Wilson, S. R.; Czarnik, A. W., Eds.; Wiley: New York, 1997; p. 119.
3. (c) Tapolczay, D. J.; Kobylecki, R. J.; Payne, L. J.; Hall, B. Chem. Ind. (London) 1998, 772.
4. (d) Wentworth, P.; Janda, K. P. Curr. Opin. Biotechnol. 1998, 9, 109.
5. (e) Czarnik, A. W. Proc. Natl. Acad. Sci. USA 1997, 94, 12738.
6. (f) Pavia, M. R. Annu. Rep. Comb. Chem. Mol Diversity 1997, 1, 3.
7. (g) Ellman, J.; Stoddard, B.; Wells, J. Proc. Natl. Acad. Sci. USA 1997, 94, 2779.
8. (h) Vandersteen, A. M.; Han, H.; Janda, K. D. Mol. Diversity 1996, 2, 89.
9. (m) Dewitt, S. H.; Czarnik, A. W. Curr. Opin. Biotechnol. 1995, 6, 640.
10. (n) Houghten, R. A. In Peptides; Gutte, B., Ed.; Academic: San Diego, 1995; p. 395.
11. Leading reviews of applications in drug discovery: (a) Dolle, R. E. Mol. Diversity 1998, 3, 199.
12. (b) Coffen, D. L.; Baldino, C. M.; Lange, M.; Tilton, R. F.; Tu, C. Med. Chem. Res. 1998, 8, 206.
13. (c) Kerwin, J. F. In Comb. Chem. Mol. Diversity Drug Discovery; Gordon, E. M.; Kerwin, J. F., Eds.; Wiley-Liss: New York, 1998; p. 475.
14. (d) Weber, L. Drug Discovery Today 1998, 3, 379.
15. (e) Kubinyi, H. Curr. Opin. Drug Discovery Dev. 1998, 1, 16.
16. (f) Fecik, R. A.; Frank, K. E.; Gentry, E. J.; Menon, S. R.; Mitscher, L. A.; Telikepalli, H. Med. Res. Rev. 1998, 18, 149.
17. (g) Veber, D. F.; Drake, F. H.; Gowen, M. Curr. Opin. Chem. Biol. 1997, 1, 151.
18. (h) Plunkett, M. J.; Ellman, J. A. Sci. Am. 1997, 276, 68.
19. (i) Maehr, H. Bioorg. Med. Chem. 1997, 5, 473.
20. (j) Patel, D. V.; Gordon, E M. Drug Discovery Today 1996, 1, 134.
21. Recent contributions: (a) Owens, T. D.; Semple, J. E. Bioorg. Med. Chem. Lett. 1998, 8, 3683.
22. (b) Semple, J. E.; Rowley, D. C.; Owens, T. D.; Minami, N. K.; Uong, T. H.; Brunck, T. K. Ibid. 1998, 8, 3525.
23. (c) Semple, J. E. Tetrahedron Lett. 1998, 39, 6645.
24. (d) Semple, J. E. Bioorg. Med Chem. Lett. 1998, 8, 2501.
25. SPS of peptide aldedydes. (a) Lelievre, D.; Chabane, H.; Delmas, A. Tetrahedron Lett. 1998, 39, 9675.
26. (b) Murphy, A. M.; Dagnino, R.; Vallar, P. L.; Trippe, A. J.; Sherman, S. L.; Lumpkin, R. H.; Tamura, S. Y; Webb, T. R. J. Am. Chem, Soc. 1992, 114, 3156.
27. (c) Paris, M.; Heitz, A.; Guerlavais, V.; Cristau, M.; Fehrentz, J. A.; Martinez, J. Ibid. 1998, 39, 7287.
28. (d) Hall, B. J.; Sutherland, J. D. Ibid. 1998, 39, 6593.
29. (e) Fehrentz, J. A.; Paris, M.; Heitz, A.; Velek, J.; Winternitz, F.; Martinez, J. J. Org. Chem. 1997, 62, 6792.
30. (f) Fehrentz, J. A.; Paris, M.; Heitz, A.; Velek, J.; Liu, C.-K; Winternitz, F.; Martinez, J. Tetrahedron Lett. 1995,36, 7871.
31. Tamura, S. Y; Semple, J. E.; Ardecky, R. J.; Leon, P.; Carpenter, S. H.; Ge, Y; Shamblin, B. M.; Weinhouse, M. I.; Ripka, W, C.; Nutt, R. F. Tetrahedron Lett. 1996, 37, 4109.
32. (a) Gibson, S. E.; Hales, N. J.; Peplow, M. A. Tetrahedron Lett. 1999, 40, 1417.
33. (b) Brown. A. R.; Rees, D. C; Rankovic, Z.; Murphy, J. R. J. Am. Chem. Soc. 1997, 119, 3288.
34. (c) Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C. Tetrahedron report no. 418, Tetrahedron 1997, 55, 5643.
35. (d) Plunkett, M. J.; Ellman, J. A. J. Org. Chem. 1997, 62, 2885.
36. All new intermediates were characterized by full spectroscopic (IR, NMR, low/high resolution MS) data. Yields refer to spectroscopically and chromatographically homogenous (=95% by HPLC, TLC) materials.
37. Semple, J. E.; Rowley, D. C.; Brunck, T. K.; Uong, T. H.; Minami, N. K.; Owens, T. D.; Tamura, S. Y; Goldman, E. A.; Siev, D. V.; Ardecky, R. J.; Carpenter, S. H.; Ge, Y.; Richard, B. M; Nolan, T. G.; Håkanson, K.; Tulinsky, A.; Nutt, R. F.; Ripka, W. C. J. Med. Chem. 1996, 39, 4531.
38. Coste, J.; Le Nguyen, D.; Castro, B. Tetrahedron Lett. 1990, 31, 205 and references cited therein.
39. (a) Lloyd-Williams, P.; Jou, G.; Albericio, R; Giralt, E. Tetrahedron Lett. 1991, 32, 4207.
40. (b) Kunz, H.; Dombo, B. Angew. Chem., Int. Ed. Engl. 1988, 27, 711.
41. (a) Jurczak, J.; Golebiowski, A. Chem. Rev. 1989, 89, 149.
42. (b) Ho, P. T.; Ngu, K. J. Org. Chem. 1993, 58, 2313.
43. (c) Hyun, S. I.; Kim, Y. G. Tetrahedron Lett. 1998, 39, 4299.
44. Otto, H.-H.; Schirmeister, T. Chem. Rev. 1997, 97, 133.